RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Dr. Patrick Hemmons travelled to Seattle to get an RSV shot for his daughter. He says he hopes to see nirsevimab become more ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Here is what to know about RSV, including its symptoms, treatment options and when to see a doctor. RSV is a common respiratory virus that causes mild, cold-like symptoms in healthy adults.

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

Similarly to common colds, mild cases of RSV generally resolve on their own within one to two weeks, according to the CDC. The Cleveland Clinic suggests the following treatment while ill ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

The Health Department of Northwest Michigan is reporting an increase in respiratory illnesses across Antrim, Charlevoix, ...